CoChat

Blockade of CD40–CD40 Ligand Interactions Protects against Radiation-Induced Pulmonary Inflammation and Fibrosis

Open access
Adawi, Adnan, Zhang, Ying, Baggs, Raymond, Rubin, Philip, Williams, Jacqueline, Finkelstein, Jacob, Phipps, Richard P. · 1998 · Clinical Immunology and Immunopathology
Cited by 83

The DOI matches its Crossref record.

Abstract

This study investigated whether CD40-CD40 ligand (L) interactions are important in mediating ionizing radiation-induced lung toxicity. Radiotherapy is a key component in the management of malignant diseases and is a conditioning regimen for bone marrow transplantation. Unfortunately, radiation therapy is particularly toxic to the lung, potentially inducing a fatal pneumonitis and fibrosis, thus limiting its effectiveness. There are no therapies that protect against the development of radiation-induced lung toxicity. Using a mouse model of radiation-induced lung toxicity, a monoclonal anti-CD40L antibody (MR1) that disrupts CD40-CD40L interactions was tested for the ability to reduce lung injury. C57BL/6 mice were pretreated with either nothing, MR1, or hamster IgG 24 h prior to a single dose of 15 Gray ionizing radiation to the thorax. During the following 26 weeks, mice continued to receive MR1 or hamster IgG twice per week. MR1 protected against death from radiation pneumonitis and fibrosis and dramatically reduced lung pathology as evidenced by a limited influx of inflammatory cells, minimal collagen deposition, and septal thickening. MR1 also prevented radiation-induced pulmonary mastocytosis and blunted expression of cyclooxygenase-2, a proinflammatory enzyme responsible for prostaglandin synthesis. Disruption of CD40-CD40L interactions may offer a new mode of intervention to protect against radiation-induced pulmonary toxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1006/clin.1998.4606

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 83

Metadata

Authors
Adawi, A., Zhang, Y., Baggs, R., Rubin, P., Williams, J., Finkelstein, J., & Phipps, R. P.
Venue
Clinical Immunology and Immunopathology
Publisher
Elsevier BV
Published
1998-12
Volume
89
Issue
3
Pages
222-230
ISSN
0090-1229 (ISSN-L)
OpenAlex
W2021421029
Cited by
83
References
0
FWCI
5.45
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blockade of CD40–CD40 Ligand Interactions Protects against Radiation-Induced Pulmonary Inflammation and Fibrosis. https://app.cochat.ai/papers/10.1006/clin.1998.4606
The paper
Adawi, A., Zhang, Y., Baggs, R., Rubin, P., Williams, J., Finkelstein, J., & Phipps, R. P. (1998). Blockade of CD40–CD40 Ligand Interactions Protects against Radiation-Induced Pulmonary Inflammation and Fibrosis. Clinical Immunology and Immunopathology. https://doi.org/10.1006/clin.1998.4606

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.